Creation of patterns in fibrous matrices using localized dissolution printing
View Patent ↗A method for fabricating a patterned fibrous matrix includes providing a printer adapted to use an etching solvent as an ink; providing to the printer a fibrous matrix to use as a printing medium; providing to the printer a pattern for printing on the fibrous matrix; printing by the printer the pattern on the fibrous matrix; and receiving from the printer the patterned fibrous matrix with the pattern etched thereon.
1. A method for fabricating a patterned fibrous matrix, comprising the steps of:
providing an inkjet printer adapted to use an etching solvent as an ink;
providing a fibrous matrix, including a plurality of fibers, as a printing medium;
providing said etching solvent for said inkjet printer, said etching solvent being adapted to at least partially dissolve said plurality of fibers of said fibrous matrix upon contact of said etching solvent to said plurality of fibers;
configuring said inkjet printer to print a pattern on said fibrous matrix;
operating said inkjet printer to print said pattern on said fibrous matrix by contacting some of said plurality of fibers with said etching solvent to produce contacted fibers, said etching solvent forming said pattern by at least partially dissolving some of said contacted fibers to form a printed area on said fibrous matrix and fusing together others of said contacted fibers to form fused fibers, said fused fibers being thicker than unfused fibers of said plurality of fibers of said fibrous matrix.
2. The method of claim 1 , wherein said etching solvent includes one or more of hexafluoroisopropanol, dimethylformamide, dichloromethane, chloroform, trifluoroethanoic acid, water, a protein, a peptide, a hormone, a cell, DNA, and bovine serum albumin.
3. The method of claim 2 , wherein said etching solvent includes hexafluoroisopropanol and dimethylformamide at a ratio of about 9:1.
4. The method of claim 2 , wherein said etching solvent includes hexafluoroisopropanol and bovine serum albumin.
5. The method of claim 1 , wherein said fibrous matrix includes one or more of polycaprolactone, collagen, poly(lactic-co-glycolic acid), polyethylene glycol, poly(ethylene oxide), fibrinogen, gelatin, polylactic acid, and polyglycolic acid.
6. The method of claim 5 , wherein said fibrous matrix includes a polycaprolactone (8%)/collagen (8%) (1:1 v/v) blend solution.
7. The method of claim 1 , wherein said fibrous matrix is fabricated by a process including electrospinning.
8. The method of claim 1 , wherein said inkjet printer includes a piezoelectric inkjet printer.
9. The method of claim 1 , wherein said patterned fibrous matrix includes a three-dimensional construct.
10. The method of claim 1 , wherein said patterned fibrous matrix includes a groove having a width less than about 100 μm.
11. The method of claim 1 , further comprising the step of culturing a cell culture on said patterned fibrous matrix.
12. The method of claim 11 , wherein said cell culture includes one of normal human dermal fibroblast cells, mouse endothelial cells, and human fetal neural stem cells.
13. The method of claim 1 , further comprising the step of configuring a printing parameter of said inkjet printer based on a desired parameter of said patterned fibrous matrix.
14. The method of claim 13 , wherein said printing parameter is one of a drop size, a drop distance, and a quantity of printing nozzles.
15. The method of claim 14 , wherein said drop size is in a range from about 3.75 picoliters to about 10 picoliters.
16. The method of claim 14 , wherein said drop distance is a range from about 15 microns to about 90 microns.
17. The method of claim 14 , wherein said quantity of printing nozzles is in a range from one to sixteen.
18. The method of claim 13 , wherein said parameter of said patterned fibrous matrix is one of a pore size and a width of an unprinted area.
19. The method of claim 1 , wherein said pattern is formatted in a computer-aided design format.